AmSurg Corp (AMSG.OQ)

AMSG.OQ on NASDAQ Stock Exchange Global Select Market

49.50USD
1 Oct 2014
Price Change (% chg)

$-0.55 (-1.10%)
Prev Close
$50.05
Open
$50.00
Day's High
$50.00
Day's Low
$49.50
Volume
2,777
Avg. Vol
151,477
52-wk High
$54.48
52-wk Low
$39.31

AMSG.OQ

Chart for AMSG.OQ

About

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (ASCs) in the United States. An AmSurg surgery centers are typically located adjacent to or in close proximity to the medical practices of its partner physicians. Its surgical facilities primarily provide non-elective, high volume, lower-risk... (more)

Overall

Beta: 1.06
Market Cap (Mil.): $2,407.84
Shares Outstanding (Mil.): 48.11
Dividend: --
Yield (%): --

Financials

  AMSG.OQ Industry Sector
P/E (TTM): 22.11 28.78 34.07
EPS (TTM): 2.26 -- --
ROI: 16.84 8.45 17.40
ROE: 9.55 13.04 18.25
Search Stocks

Amsurg to expand into physician services with $2.35 billion deal

- Ambulatory surgery center operator Amsurg Corp said it would buy Sheridan Healthcare Inc from private equity firm Hellman & Friedman LLC for about $2.35 billion in cash and stock to enter the outsourced physician services market.

29 May 2014

UPDATE 2-Amsurg to expand into physician services with $2.35 bln deal

May 29 - Ambulatory surgery center operator Amsurg Corp said it would buy Sheridan Healthcare Inc from private equity firm Hellman & Friedman LLC for about $2.35 billion in cash and stock to enter the outsourced physician services market.

29 May 2014

Amsurg to expand into physician services with $2.35 billion deal

- Ambulatory surgery center operator Amsurg Corp said it would buy Sheridan Healthcare Inc from private equity firm Hellman & Friedman LLC for about $2.35 billion in cash and stock to enter the outsourced physician services market.

29 May 2014

Amsurg to expand into physician services with $2.35 bln deal

May 29 - Surgery center operator Amsurg Corp said it would buy Sheridan Healthcare from private equity firm Hellman & Friedman in a cash and stock deal valued at about $2.35 billion to enter the outsourced physician services market.

29 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks